Quintero-Fabián Saray, Arreola Rodrigo, Becerril-Villanueva Enrique, Torres-Romero Julio César, Arana-Argáez Victor, Lara-Riegos Julio, Ramírez-Camacho Mario Alberto, Alvarez-Sánchez María Elizbeth
Multidisciplinary Research Laboratory, Military School of Graduate of Health, Mexico City, Mexico.
Psychiatric Genetics Department, National Institute of Psychiatry "Ramón de la Fuente", Clinical Research Branch, Mexico City, Mexico.
Front Oncol. 2019 Dec 6;9:1370. doi: 10.3389/fonc.2019.01370. eCollection 2019.
During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.
在血管生成过程中,新血管从现有的内皮细胞衬里血管中产生,以促进血管基底膜的降解并重塑细胞外基质(ECM),随后内皮细胞迁移、增殖并生成新的基质成分。基质金属蛋白酶(MMPs)参与破坏、肿瘤新生血管形成及随后的转移,而金属蛋白酶组织抑制剂(TIMPs)则下调这些MMPs的活性。然后,血管生成反应可由MMPs通过调节促血管生成因子和抗血管生成因子之间的平衡直接或间接介导。本综述分析了关于MMPs及其参与血管生成的最新知识。